CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
Generic Name: Raltegravir
Brand Name: Isentress
Manufacturer: Merck Frosst Canada Ltd.
Indications: HIV (treatment naïve)
Submission Type: New Indication
Project Status: Complete
Date Recommendation Issued: June 23, 2010
Recommendation Type: Do not list
